Jean Pascal Tranie

Jean-Pascal Tranie is a prominent figure in the fields of private equity and biotechnology. He serves as the Co-founder and Chairman of PepKon, a company focused on developing innovative solutions in the biotech sector, particularly in peptide-based therapies.23

Tranie is also the President of Aloe Private Equity, a fund management company that specializes in digital technologies, healthcare, and climate change. His entrepreneurial background includes co-founding DiogenX, a preclinical biotech company targeting diabetes, and previously serving as the CEO of Viventures, a significant European venture capital fund in the early 2000s. His educational credentials include degrees from Ecole Polytechnique and l’Ecole Nationale d’Administration.12

In addition to his roles at PepKon and Aloe Private Equity, Tranie has held various leadership positions, including being the CEO of Veolia Energy in Germany and serving as Multimedia Director at Vivendi, overseeing several major companies in the media and telecommunications sectors.1